Skip to main content
Top
Published in: Pediatric Cardiology 7/2018

01-10-2018 | Original Article

Comparison of Clinical Profiles in Patients with Protein-Losing Enteropathy With and Without Fontan Circulation

Authors: Shin Ono, Hideo Ohuchi, Aya Miyazaki, Osamu Yamada

Published in: Pediatric Cardiology | Issue 7/2018

Login to get access

Abstract

Protein-losing enteropathy (PLE) is a life-threatening complication in patients following the Fontan operation. However, PLE also develops in some patients with congenital heart disease (CHD) after biventricular repair (BVR). This study compared clinical profiles of PLE patients following the Fontan operation with those after BVR. We retrospectively reviewed clinical charts of postoperative CHD patients with PLE. The study population comprised 42 PLE patients (14BVR, 28Fontan). Postoperative follow-up period until onset was significantly shorter in the Fontan group than in the BVR group (14 ± 2 vs. 8 ± 1 years, p = 0.02), while there was no difference in PLE onset age between groups. Furthermore, there were no differences in prevalence of clinically relevant arrhythmias, cardiac output, or central venous pressure between the two groups at PLE onset. Percentage of structural lesions (valve regurgitation and/or stenotic lesions) responsible for development of PLE and ventricular end-diastolic pressure were higher in the BVR group than in the Fontan group (93 vs. 50%, p < 0.01), (13.4 ± 6.3 vs. 7.5 ± 4.1, p < 0.0001). Catheter intervention was applied in 2Fontan and 6BVR patients, while surgical intervention was required in 8BVR and 7Fontan patients. Of these, catheter intervention was effective in 2 (25%, 1Fontan, 1BVR) and surgical intervention was effective in 4 (26.7%, 1Fontan, 3BVR). Only one patient (5.3%) improved without intervention. Complete PLE remission rate was higher in the BVR group than in the Fontan group (38 vs. 7%, p = 0.02). During follow-up, death of 2 BVR and 8 Fontan patients occurred. There were no group differences in 5- to 10-year survival rates after PLE onset (81 vs. 81%, BVR, 81 vs. 66%, Fontan). Although BVR patients may have greater chance of PLE remission when compared with those exhibiting Fontan pathophysiology, mortality in PLE-CHD patients was significantly high regardless of postoperative hemodynamics.
Literature
1.
go back to reference John AS et al (2014) Clinical outcomes and improved survival in patients with protein-losing enteropathy after the Fontan operation. J Am Coll Cardiol 64(1):54–62CrossRef John AS et al (2014) Clinical outcomes and improved survival in patients with protein-losing enteropathy after the Fontan operation. J Am Coll Cardiol 64(1):54–62CrossRef
2.
go back to reference Feldt RH et al (1996) Protein-losing enteropathy after the Fontan operation. J Thorac Cardiovasc Surg 112(3):672–680CrossRef Feldt RH et al (1996) Protein-losing enteropathy after the Fontan operation. J Thorac Cardiovasc Surg 112(3):672–680CrossRef
3.
go back to reference Mertens L et al (1998) Protein-losing enteropathy after the Fontan operation: an international multicenter study. PLE study group. J Thorac Cardiovasc Surg 115(5):1063–1073CrossRef Mertens L et al (1998) Protein-losing enteropathy after the Fontan operation: an international multicenter study. PLE study group. J Thorac Cardiovasc Surg 115(5):1063–1073CrossRef
4.
go back to reference Davidson JD et al (1961) Protein-losing gastroenteropathy in congestive heart-failure. Lancet 1(7183):899–902CrossRef Davidson JD et al (1961) Protein-losing gastroenteropathy in congestive heart-failure. Lancet 1(7183):899–902CrossRef
5.
go back to reference Wilkinson P, Pinto B, Senior JR (1965) Reversible protein-losing enteropathy with intestinal lymphangiectasia secondary to chronic constrictive pericarditis. N Engl J Med 273(22):1178–1181CrossRef Wilkinson P, Pinto B, Senior JR (1965) Reversible protein-losing enteropathy with intestinal lymphangiectasia secondary to chronic constrictive pericarditis. N Engl J Med 273(22):1178–1181CrossRef
6.
go back to reference Zoghbi WA et al (2003) Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 16(7):777–802CrossRef Zoghbi WA et al (2003) Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 16(7):777–802CrossRef
7.
go back to reference Feltes TF et al (2011) Indications for cardiac catheterization and intervention in pediatric cardiac disease: a scientific statement from the American Heart Association. Circulation 123(22):2607–2652CrossRef Feltes TF et al (2011) Indications for cardiac catheterization and intervention in pediatric cardiac disease: a scientific statement from the American Heart Association. Circulation 123(22):2607–2652CrossRef
8.
go back to reference Bonow RO et al (2006) ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 114(5):e84–e231CrossRef Bonow RO et al (2006) ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 114(5):e84–e231CrossRef
9.
go back to reference Muller C et al (1991) Constrictive pericarditis without typical haemodynamic changes as a cause of oedema formation due to protein-losing enteropathy. Eur Heart J 12(10):1140–1143CrossRef Muller C et al (1991) Constrictive pericarditis without typical haemodynamic changes as a cause of oedema formation due to protein-losing enteropathy. Eur Heart J 12(10):1140–1143CrossRef
10.
go back to reference Ohuchi H et al (2013) Haemodynamic characteristics before and after the onset of protein losing enteropathy in patients after the Fontan operation. Eur J Cardiothorac Surg 43(3):e49-57CrossRef Ohuchi H et al (2013) Haemodynamic characteristics before and after the onset of protein losing enteropathy in patients after the Fontan operation. Eur J Cardiothorac Surg 43(3):e49-57CrossRef
11.
go back to reference Ohuchi H et al (2016) Heart failure with preserved right ventricular ejection fraction in postoperative adults with congenital heart disease: a subtype of severe right ventricular pathophysiology. Int J Cardiol 212:223–231CrossRef Ohuchi H et al (2016) Heart failure with preserved right ventricular ejection fraction in postoperative adults with congenital heart disease: a subtype of severe right ventricular pathophysiology. Int J Cardiol 212:223–231CrossRef
12.
go back to reference Mizuno M et al (2013) Experience of decortication for restrictive hemodynamics in adults with congenital heart disease. Pediatr Int 56(4):630–633CrossRef Mizuno M et al (2013) Experience of decortication for restrictive hemodynamics in adults with congenital heart disease. Pediatr Int 56(4):630–633CrossRef
Metadata
Title
Comparison of Clinical Profiles in Patients with Protein-Losing Enteropathy With and Without Fontan Circulation
Authors
Shin Ono
Hideo Ohuchi
Aya Miyazaki
Osamu Yamada
Publication date
01-10-2018
Publisher
Springer US
Published in
Pediatric Cardiology / Issue 7/2018
Print ISSN: 0172-0643
Electronic ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-018-1893-9

Other articles of this Issue 7/2018

Pediatric Cardiology 7/2018 Go to the issue